Cancer Res Commun
Biomarkers, TumorImmunotherapy
Dr. Malek Mohamad Safa, MD
NPI1427016914
- Medicare services, 2024
- 1,384
- Medicare patients, 2024
- 324
- Part D claims, 2024
- 1,668
- Publications
- 4
- Clinical trials
- 1
- Practice address
- 405 Grand Avenue, Dayton, OH 45405
- Practice phone
- Call (937) 723-3410
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Safa's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Malek Mohamad Safa is a hematologist and oncologist in Dayton, Ohio
Dr. Safa practices at Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare.
Dr. Safa's NPI, 1427016914, was assigned on May 3, 2006. Dr. Safa holds Ohio license 35-074409.
NPI and contact details
- NPI
- 1427016914NPI Registry (opens in a new tab)
- NPI enumeration date
- May 3, 2006
- NPI status
- Active
- Practice phone
- (937) 723-3410
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Malek Mohamad Safa practices at Kettering Health Dayton in Dayton, Ohio
Dr. Safa's primary practice is Kettering Health Dayton, at 405 Grand Avenue, Dayton, OH 45405 in Montgomery County. The practice phone is (937) 723-3410.
- Kettering Health Dayton405 Grand Avenue, Dayton, OH 45405 · Montgomery CountyPhone(937) 723-3410
Source: Dmand AI Affiliation Data
Dr. Malek Mohamad Safa is affiliated with 3 sites of care and 2 medical groups
Dr. Safa's primary practice is Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Safa to 2 more group practices and clinics and 1 medical group, each named with a free account.
Kettering Health Medical Group2 group practices and clinicsNames with a free account1 medical groupName with a free account
See all 5 affiliations for Dr. SafaSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Malek Mohamad Safa's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Safa practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Kettering Health Dayton | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Safa practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Kettering Adventist Healthcare and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Malek Mohamad Safa is one of 460 hematologists and oncologists in Ohio
Hematology and oncology is Dr. Safa's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Safa is licensed in Ohio.
Specialties and state licenses
- Hematology and oncology, OhioPrimary
Hematologists and oncologists near Dr. Safa
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
460hematologists and oncologists in Ohio36hematologists and oncologists in Dayton15hematologists and oncologists at Kettering Health Dayton
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Malek Mohamad Safa billed Medicare for 1,384 services in 2024
CMS data shows 1,384 Medicare services from Dr. Safa across 6 procedure codes in 2024, for 324 Medicare patients. Medicare paid $73,566 for them.
Medicare services, 20241,384
Medicare patients324
Paid by Medicare$73,566
Procedure codes6
Dr. Safa's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,4722024: 88140%
- Other services
- 2023: 02024: 503
Where Dr. Safa's Medicare services took place, 2024
- In an office1,20587%
- In a facility17913%
Dr. Safa compared with the Ohio median for hematologists and oncologists, 2024
- Dr. Safa
- Ohio median
- Medicare services
- 1,384vs 6262.2 times
- Medicare patients
- 324vs 23438% above
- Part D claims
- 1,424vs 4783.0 times
Medians across 452 hematologists and oncologists in Ohio with Dmand AI profiles that report each measure.
Dr. Safa's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Safa?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Safa and other hematologists and oncologists in Ohio.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Malek Mohamad Safa treated 324 Medicare patients in 2024, average age 75
CMS counts 324 Medicare patients who saw Dr. Safa in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Safa's median patient age at 68, with 57% women.
Medicare patients, 2024324
Average age75
Average risk score2.42
Also on Medicaid12%
Dr. Safa's Medicare patients by age, 2024
Dr. Safa's Medicare patients by sex, 2024
- Women17353%
- Men15147%
Chronic conditions among Dr. Safa's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer56%
- Arthritis54%
- Chronic kidney disease40%
- Diabetes37%
- Anxiety35%
- Ischemic heart disease35%
Share of Medicare patients with each condition. A patient can have several.
Dr. Safa's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women57%
- Men42%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Malek Mohamad Safa wrote 1,668 Medicare Part D claims in 2024
In 2024, Dr. Safa wrote 1,668 Medicare Part D claims for 237 patients. 81% of them were for generic drugs. CMS names the drug for 1,424 of them, across 34 drugs with 11 or more claims each, at $1,793,222 in total drug cost. In 2023, CMS named 2,019 claims across 41 drugs.
Part D claims, 20241,668
Drugs named by CMS34
Total drug cost$1.8M
Part D patients237
Dr. Safa's Part D claims by kind of drug, 2024
- Generic1,352 claims81%
- Brand-name and other316 claims19%
Dr. Safa's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Safa's Part D claims, 2024
- Opioids6%100 of 1,668 claims
- Antibiotics1%24 of 1,668 claims
- Antipsychotics, patients 65 and over2%38 of 1,668 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2,0192024: 1,42429%
Drugs named by CMS: 34 in 2024, 41 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Malek Mohamad Safa scored 81 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Safa for performance year 2024, reported as part of a group.
Dr. Safa's MIPS scores, performance year 2024
- 81of 100Final score
- 63.7of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Safa by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Malek Mohamad Safa has 4 publications on record
Dmand AI links 4 papers to Dr. Safa, published from 2011 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Biomarkers, Tumor. Dr. Safa's most frequent co-authors are Mark Edward Burkard, MD, Jamil Khatri, MD and Marc Ryan Matrana, MD.
Papers4
Years published2011 to 2023
Dr. Safa's papers by year, 2011 to 2023
Topics Dr. Safa writes about most
- Biomarkers, Tumor
Dr. Safa's most frequent co-authors
- Mark Edward Burkard, MD3 shared papers
- Jamil Khatri, MD3 shared papers
- Marc Ryan Matrana, MD3 shared papers
Recent publications by Dr. Safa
JCO Precis Oncol
Biomarkers, TumorGenome, HumanGenomics
Clin Lymphoma Myeloma Leuk
Antibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsLymphoma, Large B-Cell, Diffuse
See who Dr. Safa researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Safa works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Malek Mohamad Safa has worked on 1 clinical trial
Dmand AI links Dr. Safa to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders.
Conditions in Dr. Safa's trials
- Multiple Myeloma
- Blood Protein Disorders
Investigators on the most trials with Dr. Safa
- Eugene R. Ahn, MD1 shared trial
- Issam Abdelkarim Hussein Alawin, MBBS, MD1 shared trial
- Tareq Al Baghdadi, MD1 shared trial
Recent clinical trials with Dr. Safa
Multiple MyelomaBlood Protein DisordersAbemaciclibAtezolizumab and PHESGOAtezolizumab and Talazoparib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Malek Mohamad Safa received $16,126 in industry payments from 2016 to 2024
CMS Open Payments shows 34 general payments to Dr. Safa from 18 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 87% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $4,871.
General payments to Dr. Safa by program year, 2016 to 2024
General payments to Dr. Safa by kind, 2016 to 2024
$16.1Kin total
- Consulting fees$14,06887%
- Speaker and faculty fees$1,0006%
- Travel and lodging$5674%
- Food and beverage$3412%
- Education$1501%
Companies that paid Dr. Safa the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Malek Mohamad Safa's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Malek Mohamad Safa
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Malek Mohamad Safa's NPI number?
Dr. Malek Mohamad Safa's NPI number is 1427016914. It was assigned on May 3, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Malek Mohamad Safa?
Dr. Malek Mohamad Safa is a hematologist and oncologist in Dayton, Ohio. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Malek Mohamad Safa practice?
Dr. Safa practices at 405 Grand Avenue, Dayton, OH 45405. Dr. Safa's primary practice is Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare. Dmand AI also links Dr. Safa to 2 group practices and clinics and 1 medical group.
What is Dr. Malek Mohamad Safa's office phone number?
The practice phone on file for Dr. Safa is (937) 723-3410.
What is Dr. Malek Mohamad Safa's medical license number?
Dr. Safa holds Ohio license 35-074409.
Which hospitals is Dr. Malek Mohamad Safa affiliated with?
Dr. Safa practices at Kettering Health Dayton in Dayton, Ohio.
What medical group is Dr. Malek Mohamad Safa part of?
Dr. Safa is linked to Kettering Health Medical Group. Dmand AI links Dr. Safa to 1 more medical group.
Does Dr. Malek Mohamad Safa accept Medicare?
Yes. CMS data shows Dr. Safa billed Medicare for 1,384 services in 2024.
What is Dr. Malek Mohamad Safa's MIPS score?
Dr. Safa's MIPS final score for performance year 2024 is 81 out of 100, reported as part of a group.
How many Medicare patients does Dr. Malek Mohamad Safa see?
CMS counts 324 Medicare patients who saw Dr. Safa in 2024, with an average age of 75.
Show 6 more questionsShow fewer questions
What services does Dr. Malek Mohamad Safa bill to Medicare?
In 2024, Dr. Safa's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and hospital inpatient care (99233).
What drugs does Dr. Malek Mohamad Safa prescribe most?
In 2024 Medicare Part D data, Dr. Safa's most prescribed drugs by claims were Letrozole, Prednisone and Ondansetron HCl.
Has Dr. Malek Mohamad Safa received payments from drug or device companies?
CMS Open Payments shows $16,126 in general payments to Dr. Safa from 18 companies from 2016 to 2024. The largest total came from Bayer HealthCare Pharmaceuticals Inc.
How long has Dr. Malek Mohamad Safa been practicing?
Dr. Safa graduated from medical school in 1995, 31 years ago.
Does Dr. Malek Mohamad Safa do research?
Dmand AI links 4 publications to Dr. Safa, published from 2011 to 2023. Dr. Safa has worked on 1 clinical trial.
Who does Dr. Malek Mohamad Safa publish with?
Dr. Safa's most frequent co-authors are Mark Edward Burkard, MD (3 shared papers), Jamil Khatri, MD (3 shared papers) and Marc Ryan Matrana, MD (3 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Ohio by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card